Heidi Andersén’s Post

Our AI journey continues as we announced CareIntellect for Oncology, an AI-powered tool that helps clinicians gain a comprehensive view of a patient’s cancer journey in one place. The platform goes beyond data aggregation, offering an organized look at disease progression and supporting proactive care interventions. It simplifies access to patient histories, clinical trial eligibility, and treatment adherence. Tampa General Hospital and UT Southwestern Medical Center will be early evaluators. This is the first application of our GE HealthCare CareIntellect suite, designed to streamline healthcare technology adoption and improve clinical efficiency. Here is what our leaders and partners say: “CareIntellect is designed to help providers streamline access to critical patient information and surface key changes since the patient’s last visit. By ensuring the provider has the right information at their fingertips, they can spend less time sifting through information and more time helping patients.” Taha Kass-Hout, MD, MS, Global Chief Science and Technology Officer at GE HealthCare “Tampa General Hospital is looking forward to evaluating CareIntellect for Oncology to provide our care teams with information to move from analysis to action—including making use of the proactive pathways to inform care progression and clinical trial eligibility information. We were impressed by how quickly GE HealthCare was able to design the application to include breast cancer in a matter of weeks. We look forward to putting this in the hands of our care teams and using the AI-enabled functionality to help clinicians spend time where it matters most—delivering outstanding patient care.” Dr. Peter Chang Senior Vice President, Chief Transformation Officer at Tampa General Hospital. Read the full news release here and visit us at HLTH Inc. to learn more: https://lnkd.in/e8N4ctuZ #AI #GeHealthCare #oncology

Unlocking the Future of Cancer Care with Leal Health’s Award-Winning Gen-AI In the ever-evolving world of cancer treatment, ensuring the right patients receive the right medicine at the right time is more important than ever. Leal Health’s award-winning Gen-AI technology is revolutionizing the way treatment options are delivered, providing personalized, cancer-specific recommendations that are up-to-date and tailored to each individual’s unique needs. For cancer patients, this means having access to the most current and effective treatment options—without the burden of endless research or uncertainty. Our AI technology empowers you with clear, actionable information that helps guide your healthcare decisions, so you can focus on what matters most: your well-being. For commercial and brand leaders, Leal Health’s innovative Gen-AI ensures that your groundbreaking treatments are reaching the patients who need them most, when they need them. This streamlined, personalized approach helps drive brand awareness, loyalty, and ensures your treatments are utilized to their full potential, transforming the lives of patients. With Leal Health’s Gen-AI, we’re not just advancing healthcare—we’re redefining how patients and providers connect with life-saving treatments. Together, let’s bring the future of medicine to today’s patients, making cancer care more precise, accessible, and convenient for everyone. #LealHealth #AIinHealthcare #CancerCare #PatientFirst #PrecisionMedicine #HealthInnovation #GenAI #LealImpact #cancersucks

Looking forward to joining an esteemed panel of experts hailing from different parts of the cancer care continuum to discuss this important topic!

Flatiron Health, NCCN Collaborate to Advance Cancer Care with Real-World Data - HIT Consultant #FlatironHealthNCCNCollaboration Flatiron Health and NCCN have joined forces to utilize real-world data to enhance cancer care. This collaboration aims to improve outcomes for cancer patients by leveraging data-driven insights. #RealWorldDataAnalysis The partnership will focus on analyzing real-world data to identify trends, patterns, and best practices in cancer treatment. By analyzing this data, healthcare providers can make more informed decisions and improve patient outcomes. #ClinicalDecisionSupport One of the key goals of the collaboration is to develop clinical decision support tools that can help healthcare providers make evidence-based treatment decisions. These tools will be based on real-world data analysis and will provide personalized treatment recommendations for cancer patients. #EnhancedPatientCare By ai.mediformatica.com #flatiron #cancer #health #data #cancercare #this #realworlddata #research #collaboration #flatironhealth #provider #clinical #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4aRn3ox)

ARE YOU OVER 50? THEN PLEASE READ THIS. As we embark on Colorectal Cancer Awareness Month, I’m reminded of the importance of shedding light on this pressing issue impacting countless lives across Europe. Colorectal cancer stands as a significant concern, with far-reaching implications for individuals and communities alike. Early detection plays a pivotal role in enhancing treatment effectiveness and saving lives, yet despite this urgency, participation in screening programs remains low. By increasing participation, we can achieve earlier diagnosis and treatment, resulting in improved outcomes and reduces mortality rates. At Johnson & Johnson MedTech, we’re dedicated to driving change by boosting colorectal cancer screening rates. Through education, collaboration with healthcare providers, and innovative technologies, we’re committed to making screening more accessible and user-friendly. By breaking down barriers, we aim to drive meaningful improvements in early detection and treatment. We firmly believe in the power of early detection and its potential to transform lives. By identifying high-risk individuals and offering effective screening options, we can improve outcomes for patients and their loved ones. Joins us in spreading awareness and encouraging participation: please participate yourself and invite your loved ones who are 50 and above to screen regularly. Early detection can save lives and ensure a better chance of successful treatment. #ColorectalCancerAwarenessMonth #EarlyDetectionSavesLives #HealthcareInnovation 

🚀 Fueling Precision with “Next Best Action” in Cancer Care 🚀 In the fast-paced world of oncology, delivering the right information to patients and healthcare providers at the exact right moment is critical to driving engagement and positive outcomes. That’s where Leal Health steps in, providing a unique value add for any “Next Best Action” initiatives. Our AI-powered platform is designed to anticipate and support the next best move—whether it’s matching patients with the right clinical trial, ensuring seamless access to approved therapies, or offering timely financial support options. Leal’s data-driven insights and real-time engagement empower patients, caregivers, and healthcare providers to make informed, personalized decisions at every step of the journey. Why consider Leal Health as a partner in your next best action strategy? ✔️ Real-Time Insights: Our platform continuously analyzes patient needs and HCP interactions to deliver hyper-relevant information, helping you reach patients and providers precisely when they need it. ✔️ Patient-Centric Support: From education to treatment access and symptom management, Leal Health keeps patients informed and supported, turning every interaction into a step forward. ✔️ Trusted Resource: As the largest single-point-of-access cancer care platform, Leal’s engagement tools empower oncology stakeholders with data that drives impactful, meaningful actions. In the journey to improve outcomes and enhance engagement, knowing the next best action isn’t just beneficial—it’s transformative. Connect with us to see how Leal Health can elevate your initiatives with personalized, proactive support. #CancerCare #PatientSupport #NextBestAction #Oncology #LealHealth #LealImpact #realpatientsupport

𝐈𝐬 𝐩𝐢𝐞𝐜𝐢𝐧𝐠 𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐀𝐈 𝐭𝐨𝐨𝐥𝐬 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐰𝐞 𝐜𝐚𝐧 𝐝𝐨 𝐟𝐨𝐫 𝐥𝐮𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬? In the fight against lung cancer, every moment matters. Yet, many healthcare providers are juggling a patchwork of AI tools from different vendors, each designed for a specific task. The result? Systems that don't communicate, critical information slipping through the cracks, and patients who don't receive the seamless care they deserve. 𝐓𝐡𝐞𝐫𝐞 𝐡𝐚𝐬 𝐭𝐨 𝐛𝐞 𝐚 𝐛𝐞𝐭𝐭𝐞𝐫 𝐰𝐚𝐲. At Rayscape, we've created the Lung Cancer Pathway Suite—a fully integrated AI solution that supports patients throughout their entire journey. 🤝🏻 👉🏻𝐎𝐧𝐞 𝐔𝐧𝐢𝐟𝐢𝐞𝐝 𝐒𝐮𝐢𝐭𝐞: No more switching between systems or dealing with compatibility issues. 👉🏻𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞: Our AI detects all types of lung nodules—solid, part-solid, ground-glass—ensuring nothing is overlooked. 👉🏻𝐒𝐢𝐦𝐩𝐥𝐢𝐟𝐢𝐞𝐝 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰: Standardized reports and consistent interfaces make life easier for clinicians. 👉🏻𝐑𝐞𝐥𝐢𝐚𝐛𝐥𝐞 𝐒𝐮𝐩𝐩𝐨𝐫𝐭: With us, you have one dedicated team standing by your side. Because when lives are on the line, we can't afford to miss a beat. Let's unite our efforts and provide the comprehensive care our patients need. 👉 Learn more about the Rayscape Lung Cancer Pathway Suite here: https://lnkd.in/dyXBwYJC #lungcancerpathway #lungcancer #lungcancerscreening #lungcancermonitoring #lungcancerAI #radiologyAI

Colorectal Cancer: Signs and Symptoms At the intersection of healthcare and innovation, understanding and addressing colorectal cancer is essential to improving outcomes in Africa’s oncology landscape.Early intervention is vital, and we must equip our patients with knowledge to recognize the signs. As part of our "Listen to Your Body" series, we are raising awareness about colorectal cancer—a disease that often starts silently but can have serious consequences if left undetected. Early detection through advanced technologies and streamlined workflows is vital for improving patient care. Empowering Patients Through Innovation To combat colorectal cancer effectively, we must integrate prevention and diagnosis with cutting-edge automation technologies. We can leverage automation in our practice through: Annual Reminders: Automated systems can send patients timely reminders for screenings, fostering proactive health management. Long-Term Data Tracking: Encourage the use of technology that enables tracking of patient history, which aids in personalized care and early detection. Streamlined Workflows: Implement innovative tools to enhance diagnostic accuracy and treatment processes, ultimately improving patient outcomes. Regular screening is your first line of defense. Use innovative technologies to improve diagnosis and streamline patient workflows. As oncology professionals, we play a crucial role in empowering our communities. Share this information with your patients to encourage regular screenings and awareness of early warning signs. Join the Movement! By promoting knowledge and leveraging automation, we can work together to reduce the impact of cancer in our communities. Let’s encourage our patients to listen to their bodies and take action for their health. #ColorectalCancer #CancerAwareness #OncologyProfessionals #PatientEmpowerment #AutomationInHealthcare

⏳ Just 2 weeks to go until the Clinical Pathways Congress + Cancer Care Business Exchange in Boston! The event brings together industry leaders, healthcare professionals, researchers, payment reform experts, and innovators to discuss and showcase transformative oncology delivery, payment, and business models. I am excited to participate in this panel with James Hamrick, Jeff Hunnicutt, and Will Shapiro. These are important topics, and these guys know their stuff. By exploring innovative strategies and solutions, we aim to transform the current cancer care landscape, ensuring better access, higher quality care, and improved patient outcomes. Together, we will delve into complex topics such as the role of AI in oncology, the significance of and barriers to effective clinical trial recruitment in the community setting, the power and impact of vertical integration, trends in practice consolidation, the EOM outlook from diverging perspectives, and so much more. We invite you to refine your approach in Boston on September 6–8, 2024. 🔑 Use code VIP to save 15% on registration. https://lnkd.in/gmCpcGgW #pathwaysexchange #clinicalpathwayscongress #cancercarebusinessexchange #TensorBlack AI in Precision Oncology TensorBlack

The transformative role of digital health innovations in cancer care is a hot topic at #ASCO24 in Chicago, one of the most significant gatherings of oncologists worldwide. Even as 5-year cancer survival rates have increased, the rates of more than a dozen cancers are rapidly rising around the world among adults under age 50. Models based on global data predict the number of early-onset cancer cases will increase by 30% by 2030. In the U.S., colorectal cancer has become the leading cause of cancer death among men under 50. It’s the second leading cause of cancer death in young women. #Digitalhealth solutions can play a significant role in cancer care, earlier detection, and more effective prevention. 🧬 #AI-driven diagnostics can facilitate earlier and more accurate detection 🧬 #Telemedicine platforms can bridge distance gaps to secure more timely consultations 🧬 #Quantum technologies can accelerate drug discovery and the development of personalized drug treatment plans 🧬 #Bigdata analytics can shape and sharpen treatment plans (a big discussion point at ASCO), supported by a steady flow of data from wearables and remote patient monitoring technologies 🧬 #Mobileapps for mental health support can be tailored to support cancer patients (a lot of energy around this as an under-discussed and under-served component of cancer care) As our Ascent Strategy Group team makes the rounds, presents our new tools, and establishes new collaborations, we’ve been lifted by the passion among attendees to serve patients. That passion is palpable, powerful and inspirational. #oncology #oncologists #cancercare